G400 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset G4000 Localization-related (focal) (partial) idiopathic epilepsy and ...

Credit: Endo, Inc At this time, there have been no reports of adverse events related to this recall. While the blister strips ...

Seventy-six items achieved consensus, including indications for LDOM versus topical minoxidil, dosing for adults and teens, contraindications ...

Miplyffa was approved in September 2024 based on data from a clinical trial that showed arimoclomol plus miglustat slowed NPC disease progression.

F19122 Other psychoactive substance abuse with intoxication with perceptual disturbances F19129 Other psychoactive substance abuse with intoxication, unspecified F1913 Other psychoactive substance ...

In a subgroup analysis, there was a positive effect in people with obesity, with significant reductions in brain reward center cue reactivity on functional magnetic resonance imaging. (HealthDay ...

The BLA approval is supported by data from the COBLT study, FDA dockets and public information, and from a RegeneCyte observational database.

Maternal vaccination two to three or three to four weeks before delivery linked to lower cord:maternal transfer ratios versus at least five weeks ...